Dr. Rachael Turner, MD

Claim this profile

University of Rochester Medical Center

Studies Microsatellite Instability

Studies Melanoma

1 reported clinical trial

2 drugs studied

Area of expertise

1Microsatellite Instability

Rachael Turner, MD has run 1 trial for Microsatellite Instability. Some of their research focus areas include:

Stage IV

BRAF positive

MSI-H positive

2Melanoma

Rachael Turner, MD has run 1 trial for Melanoma. Some of their research focus areas include:

Stage IV

BRAF positive

MSI-H positive

Affiliated Hospitals

University Of Rochester Medical Center

Clinical Trials Rachael Turner, MD is currently running

More about Rachael Turner, MD

Clinical Trial Related7 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial

Treatments Rachael Turner, MD has experience with

Nivolumab
RP1

Breakdown of trials Rachael Turner, MD has run

Microsatellite Instability

RP1 + Nivolumab for Cancer

Melanoma

RP1 + Nivolumab for Cancer

Skin Cancer

RP1 + Nivolumab for Cancer

Cancer

RP1 + Nivolumab for Cancer

Non-Small Cell Lung Cancer

RP1 + Nivolumab for Cancer

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

What does Rachael Turner, MD specialize in?

Rachael Turner, MD focuses on Microsatellite Instability and Melanoma. In particular, much of their work with Microsatellite Instability has involved Stage IV patients, or patients who are BRAF positive.

Is Rachael Turner, MD currently recruiting for clinical trials?

Yes, Rachael Turner, MD is currently recruiting for 1 clinical trial in Rochester New York. If you're interested in participating, you should apply.

Are there any treatments that Rachael Turner, MD has studied deeply?

Yes, Rachael Turner, MD has studied treatments such as Nivolumab, RP1.

What is the best way to schedule an appointment with Rachael Turner, MD?

Apply for one of the trials that Rachael Turner, MD is conducting.

What is the office address of Rachael Turner, MD?

The office of Rachael Turner, MD is located at: University of Rochester Medical Center, Rochester, New York 14642 United States. This is the address for their practice at the University of Rochester Medical Center.

Is there any support for travel costs?

The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.

Top trials Rachael Turner, MD is currently running

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Directories

Locations

Psychology Related

Treatments

Cities

···

Dr. Rachael Turner, MD

University of Rochester Medical Center

Area of expertise

Affiliated Hospitals

Clinical Trials Rachael Turner, MD is currently running

More about Rachael Turner, MD

Other Doctors you might be interested in

Frequently asked questions

Personalize Your Experience

Save Your Preferences

Understand How the Site Is Used

Dr. Rachael Turner, MD

University of Rochester Medical Center

Area of expertise

Affiliated Hospitals

Clinical Trials Rachael Turner, MD is currently running

RP1 + Nivolumab

for Cancer

More about Rachael Turner, MD

Other Doctors you might be interested in

Frequently asked questions